CSF levels of YKL-40 are increased in MS and decrease with immunosuppressive treatment
- 1 April 2014
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 269 (1-2) , 87-89
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effects of Natalizumab Treatment on the Cerebrospinal Fluid Proteome of Multiple Sclerosis PatientsJournal of Proteome Research, 2013
- Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosisMultiple Sclerosis Journal, 2010
- Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosisBrain, 2010
- In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseasesJournal of Neuroinflammation, 2010
- IMMUNOLOGY OF MULTIPLE SCLEROSISAnnual Review of Immunology, 2005
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 2001
- CD 14 mediates endotoxin induction of nitric oxide synthase in cultured brain glial cellsJournal of Neuroimmunology, 1996
- Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family.Journal of Biological Chemistry, 1993
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990